Relsys
Software DevelopmentUnited States51-200 Employees
Oracle has acquired Relsys. Adds Advanced Drug Safety and Risk Management Applications to Extend Oracle’s Leadership in Health Sciences
Healthcare Expansion The acquisition of Relsys enhances Oracle’s offerings in health sciences, particularly in advanced drug safety and risk management applications, opening opportunities to target pharmaceutical companies, biotech firms, and healthcare providers seeking integrated software solutions.
Cloud Infrastructure Growth Oracle's recent launch of a second public cloud region in Italy demonstrates its commitment to expanding cloud capacity and global reach, presenting sales potential with multinational organizations and regional enterprises looking to enhance cloud presence and compliance.
Cybersecurity and Data Security Ongoing issues with data breaches and cybersecurity threats highlight a demand for robust security solutions, providing an opening to offer Oracle’s security services and risk management tools to clients prioritizing protection and compliance.
Strategic Partnerships New collaborations with firms like Viva and Ajman Bank in digital solutions and trade finance illustrate opportunities to develop joint offerings or upsell Oracle cloud services to financial institutions and telecom providers aiming for digital transformation.
AI and Innovation Recognition Oracle’s repeated recognition as a leader in risk and AI technology signals advanced capabilities that can be leveraged to attract enterprises looking to incorporate AI-driven insights into their operations, particularly within regulated or data-sensitive industries.
Relsys uses 8 technology products and services including WordPress, IBM Storage, Next.js, and more. Explore Relsys's tech stack below.
| Relsys Email Formats | Percentage |
| FirstL@relsys.net | 64% |
| First.Last@relsys.net | 36% |
| First.Last@oracle.com | 96% |
| Last.First@oracle.com | 2% |
| First-L@oracle.com | 1% |
| First.Middle.Last@oracle.com | 1% |
Software DevelopmentUnited States51-200 Employees
Oracle has acquired Relsys. Adds Advanced Drug Safety and Risk Management Applications to Extend Oracle’s Leadership in Health Sciences
Relsys has raised a total of $65M of funding over 1 rounds. .
Relsys's revenue is estimated to be in the range of $25M$50M
Relsys has raised a total of $65M of funding over 1 rounds. .
Relsys's revenue is estimated to be in the range of $25M$50M